Psoriasis Clinical Trials

Showing 301-320 of 478 trials

Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

NCT03223012

This study aims to evaluate the impact of AbbVie Care 2.0 on adalimumab's compliance, patient reported outcomes and utilization of health resources over 12 months.

Crohn's DiseaseUlcerative Colitis (UC)Rheumatoid Arthritis (RA)+4 more

AbbVie116 participantsStarted Nov 2017

Lisbon, Lisbon District, Portugal • Lisbon, Lisbon District, Portugal • Lisbon, Lisbon District, Portugal +12 more locations

COMPLETEDPHASE3

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

NCT02515097

This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \[IGA\] score of 3 or 4).

Plaque Psoriasis

Bausch Health Americas, Inc.213 participantsStarted Nov 2015

Santa Ana, California, United States • Boynton Beach, Florida, United States • Clearwater, Florida, United States +12 more locations

Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Related Searches

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream

Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study

Efficacy and Tolerability of Enstilar® in Daily Practice

Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

Immune Metabolic Associations in Psoriatic Arthritis

Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis

BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis

The Association Between Psoriasis and Intestinal Bacterial Population

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis

Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis